665 related articles for article (PubMed ID: 12050367)
1. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
Joshi P; Prasad VR
J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
[TBL] [Abstract][Full Text] [Related]
2. RNA-protein interactions govern antiviral specificity and encapsidation of broad spectrum anti-HIV reverse transcriptase aptamers.
Lange MJ; Nguyen PDM; Callaway MK; Johnson MC; Burke DH
Nucleic Acids Res; 2017 Jun; 45(10):6087-6097. PubMed ID: 28334941
[TBL] [Abstract][Full Text] [Related]
3. Mutations that confer resistance to template-analog inhibitors of human immunodeficiency virus (HIV) type 1 reverse transcriptase lead to severe defects in HIV replication.
Fisher TS; Joshi P; Prasad VR
J Virol; 2002 Apr; 76(8):4068-72. PubMed ID: 11907245
[TBL] [Abstract][Full Text] [Related]
4. Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase.
Burke DH; Scates L; Andrews K; Gold L
J Mol Biol; 1996 Dec; 264(4):650-66. PubMed ID: 8980676
[TBL] [Abstract][Full Text] [Related]
5. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
[TBL] [Abstract][Full Text] [Related]
6. Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication.
Joshi PJ; North TW; Prasad VR
Mol Ther; 2005 May; 11(5):677-86. PubMed ID: 15851006
[TBL] [Abstract][Full Text] [Related]
7. High-throughput sequence analysis reveals structural diversity and improved potency among RNA inhibitors of HIV reverse transcriptase.
Ditzler MA; Lange MJ; Bose D; Bottoms CA; Virkler KF; Sawyer AW; Whatley AS; Spollen W; Givan SA; Burke DH
Nucleic Acids Res; 2013 Feb; 41(3):1873-84. PubMed ID: 23241386
[TBL] [Abstract][Full Text] [Related]
8. Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase.
DeStefano JJ; Nair GR
Oligonucleotides; 2008 Jun; 18(2):133-44. PubMed ID: 18637731
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.
Somasunderam A; Ferguson MR; Rojo DR; Thiviyanathan V; Li X; O'Brien WA; Gorenstein DG
Biochemistry; 2005 Aug; 44(30):10388-95. PubMed ID: 16042416
[TBL] [Abstract][Full Text] [Related]
10. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.
Andreola ML; Pileur F; Calmels C; Ventura M; Tarrago-Litvak L; Toulmé JJ; Litvak S
Biochemistry; 2001 Aug; 40(34):10087-94. PubMed ID: 11513587
[TBL] [Abstract][Full Text] [Related]
11. Virion encapsidation of tRNA(3Lys)-ribozyme chimeric RNAs inhibits HIV infection.
Westaway SK; Cagnon L; Chang Z; Li S; Li H; Larson GP; Zaia JA; Rossi JJ
Antisense Nucleic Acid Drug Dev; 1998 Jun; 8(3):185-97. PubMed ID: 9669656
[TBL] [Abstract][Full Text] [Related]
12. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
[TBL] [Abstract][Full Text] [Related]
13. Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cells.
El Dirani-Diab R; Sarih-Cottin L; Delord B; Dumon B; Moreau S; Toulme JJ; Fleury H; Litvak S
Antimicrob Agents Chemother; 1997 Oct; 41(10):2141-8. PubMed ID: 9333039
[TBL] [Abstract][Full Text] [Related]
14. Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.
Chaloin L; Lehmann MJ; Sczakiel G; Restle T
Nucleic Acids Res; 2002 Sep; 30(18):4001-8. PubMed ID: 12235384
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
16. Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions.
Ventura M; Tarrago-Litvak L; Dollé V; Nguyen CH; Legraverend M; Fleury HJ; Litvak S
Arch Virol; 1999; 144(3):513-23. PubMed ID: 10226617
[TBL] [Abstract][Full Text] [Related]
17. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
[TBL] [Abstract][Full Text] [Related]
18. PMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanisms.
Buckheit RW; Lackman-Smith C; Snow MJ; Halliday SM; White EL; Ross LJ; Agrawal VK; Broom AD
Antivir Chem Chemother; 1999 Jan; 10(1):23-32. PubMed ID: 10079876
[TBL] [Abstract][Full Text] [Related]
19. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
[TBL] [Abstract][Full Text] [Related]
20. Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication.
Rawle DJ; Li D; Wu Z; Wang L; Choong M; Lor M; Reid RC; Fairlie DP; Harris J; Tachedjian G; Poulsen SA; Harrich D
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
